Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- NPTN -10.4%, (implements certain restructuring actions, cuts Q3 outlook), CATO -1.3%, (Sep comps)
Other news:
- GSAT -12.3% (commencs offering of $125 mln in shares of voting common stock )
- EBIO -10.1% (files for $12.5 mln common stock offering)
- IMGN -9.1% (commences 13 mln common stock offering)
- ECYT -8.7% (cautious mention by biotech blogger Adam Feuerstein)
- USAU -8.4% (thinly traded; to offer and sell shares of common stock in 'firm commitment' underwritten public offering)
- DRAD -7.4% (lower after disclosing subsidiary received a notice of termination from Philips (PHG); conducting an impairment review)
- MTDR -4% (prices 8 mln share offering for gross proceeds of $210.8 mln)
- EKSO -3.3% ( files for 20,534,898 share common stock offering by holders)
- RIGL -3.3% (prices offering of 18.1 mln shares of common stock at $3.35 per share)
- TROX -2.3% (upsizes and prices secondary offering by selling shareholder, Exxaro Resources, of 19.5 mln shares of common stock at $22.00 per share), .
Analyst comments:
- MNK -3.4% (downgraded to Hold from Buy at Canaccord Genuity)
- CELG -2.6% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- MNTA -2.3% (downgraded to Hold at Stifel)
- GRUB -2% (downgraded to Neutral from Buy at Citigroup)
- WDC -1.6% (downgraded to Hold from Buy at Deutsche Bank)
- COH -1.3% (downgraded to Neutral from Overweight at Piper Jaffray)
- KMX -1.1% (downgraded to Perform from Outperform at Oppenheimer)